Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs

Stuart Creton(National Centre for the Replacement Refinement and Reduction of Animals in Research), Hemad Yasaei(Brunel University of London), Paul L. Carmichael(Unilever (United Kingdom)), Andrew D. Scott(Pfizer (United States)), James Harvey(GlaxoSmithKline (United Kingdom)), Noriho Tanaka(Food and Drug Safety Center), Kamala Pant(BioReliance (United States)), Marilyn J. Aardema(Procter & Gamble (United States)), Mike O’Donovan(AstraZeneca (United Kingdom)), Albrecht Poth, Rhine R. Shen(Broad Institute), Francis Martin(Chinese Academy of Sciences), Leonard M. Schechtman, Kazuo Sasaki(Food and Drug Safety Center), Robert F. Newbold(Brunel University of London), Ayako Sakai(Genesis Laboratories)
Mutagenesis
August 17, 2011
Cited by 85


Related Papers